Comptroller General review of Anomalous Health Incidents Cross-Functional Team

(a) In general The Comptroller General of the United States shall conduct a review of the Anomalous Health Incidents Cross-Functional Team of the Department of Defense established under section 910 of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117–81; 10 U.S.C. 111 note) (in this section referred to as the cross-functional team). (b) Elements The review required by subsection (a) shall include an assessment of, at a minimum, the following: (1) The activities of the cross-functional team conducted in fulfillment of each of the duties under section 910(b) of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117–81; 10 U.S.C. 111 note), during the period beginning on February 1, 2024, and ending on February 1, 2026. (2) The composition and resourcing of the cross-functional team during that period, including increases or decreases in the number of assigned or detailed personnel. (3) Any findings by the cross-functional team regarding the causes and sources of anomalous health incidents, including identification of any individuals, entities, capabilities, or phenomena to which such incidents may plausibly be attributed. (4) The decision-making process and justification for the transfer of the cross-functional team from the Office of the Under Secretary of Defense for Policy to the Office of the Under Secretary of Defense for Research and Engineering. (5) Support provided to the cross-functional team by the Defense Intelligence Agency, the National Security Agency, the National Ground Intelligence Center, and other elements of the defense intelligence enterprise since the establishment of the cross-functional team. (6) Recommendations for clarifying or strengthening the duties of the cross-functional team under section 910(b) of the National Defense Authorization Act for Fiscal Year 2022. (7) Any other matters the Comptroller General considers relevant. (c) Briefing and results The Comptroller General shall— (1) not later than 180 days after the date of the enactment of this Act, brief the congressional defense committees, the Select Committee on Intelligence of the Senate, and the Permanent Select Committee on Intelligence of the House of Representatives on the review conducted under subsection (a); and (2) provide the final results of the review to those committees in a format, and at a time, mutually agreed upon by those committees and the Comptroller General.